Source: BioPharma Dive

Function: Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment

The startup says its genomics platform can improve on conventional sequencing by uncovering drug target vulnerabilities directly in patient tumor samples.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Srinath Sampath's photo - Co-Founder & CEO of Function

Co-Founder & CEO

Srinath Sampath

CEO Approval Rating

90/100

Read more